NCT00651066 Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in Vietnam Status COMPLETED Phase PHASE2
NCT00647205 Evaluation of 2 Interferon γ Assays in the Diagnosis of Latent Tuberculosis in HIV-infected Patients.ANRS EP 40 QUANTI SPOT Status COMPLETED Phase PHASE4
NCT00645697 Intravitreal Bevacizumab in Recalcitrant Inflammatory Ocular Neovascularization Status COMPLETED Phase N/A
NCT00640887 Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in South Africa Status COMPLETED Phase PHASE2
NCT00621322 Safety and Immunogenicity Study of GSK Biologicals Tuberculosis Vaccines (692342) to Healthy Adults Status COMPLETED Phase PHASE2
NCT00620438 Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients Status UNKNOWN Phase PHASE4
NCT00617643 Nevirapine Drug Levels in HIV Positive Patients Also Receiving Rifampicin for Tuberculosis Status COMPLETED Phase PHASE4
NCT00604617 Interferon-Gamma Release Assays in Tuberculosis (TB) - HIV Co-infected Children Status COMPLETED Phase N/A
NCT00595907 Results of an Interferon-Gamma Release Assay After Treatment for Tuberculosis Status COMPLETED Phase N/A
NCT00564642 Investigation of the Effect of N Acetylcysteine Against Anti-Tuberculosis Drugs Induced Liver Toxicity Status COMPLETED Phase NA
NCT00560521 Continuous Positive Airway Pressure on Tuberculosis Pleural Effusion Status COMPLETED Phase NA
NCT00557765 Use of a Gamma-IFN Assay in Contact Tracing for Tuberculosis in a Low-Incidence, High Immigration Area Status COMPLETED Phase N/A
NCT00546273 Clinical Trial to Study 4 Different Doses of the Vaccine RUTI in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT00541294 Diagnosis of Tuberculosis Infection in HIV Co-infected Children Status COMPLETED Phase N/A
NCT00533390 Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg Status TERMINATED Phase PHASE4
NCT00523926 TMC207-C202: Study to Evaluate Bactericidal Activity of Multiple Oral Doses of TMC207 in Subjects With Sputum-Smear Positive Tuberculosis Status COMPLETED Phase PHASE2